找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Pharmaceutical Suspensions; From Formulation Dev Alok K. Kulshreshtha,Onkar N.‘Singh,G. Michael Wal Book 2010 Springer-Verlag New York 2010

[復(fù)制鏈接]
查看: 14021|回復(fù): 35
樓主
發(fā)表于 2025-3-21 16:55:30 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Pharmaceutical Suspensions
副標(biāo)題From Formulation Dev
編輯Alok K. Kulshreshtha,Onkar N.‘Singh,G. Michael Wal
視頻videohttp://file.papertrans.cn/746/745552/745552.mp4
概述Written by experienced experts in applicable field from academia/industry/regulatory agencies, volume will systematically discuss the development of stable pharmaceutical suspensions
圖書封面Titlebook: Pharmaceutical Suspensions; From Formulation Dev Alok K. Kulshreshtha,Onkar N.‘Singh,G. Michael Wal Book 2010 Springer-Verlag New York 2010
描述The suspension dosage form has long been used for poorly soluble active ingre- ents for various therapeutic indications. Development of stable suspensions over the shelf life of the drug product continues to be a challenge on many fronts. A good understanding of the fundamentals of disperse systems is essential in the development of a suitable pharmaceutical suspension. The development of a s- pension dosage form follows a very complicated path. The selection of the proper excipients (surfactants, viscosity imparting agents etc.) is important. The particle size distribution in the finished drug product dosage form is a critical parameter that significantly impacts the bioavailability and pharmacokinetics of the product. Appropriate analytical methodologies and instruments (chromatographs, visco- ters, particle size analyzers, etc.) must be utilized to properly characterize the s- pension formulation. The development process continues with a successful scale-up of the manufacturing process. Regulatory agencies around the world require cli- cal trials to establish the safety and efficacy of the drug product. All of this devel- ment work should culminate into a regulatory filing in ac
出版日期Book 2010
關(guān)鍵詞Formulation; Kulshreshtha; Singh; Suspentions; Wall; clinical trial; development; drug; kinetics; manufacturi
版次1
doihttps://doi.org/10.1007/978-1-4419-1087-5
isbn_softcover978-1-4899-8417-3
isbn_ebook978-1-4419-1087-5
copyrightSpringer-Verlag New York 2010
The information of publication is updating

書目名稱Pharmaceutical Suspensions影響因子(影響力)




書目名稱Pharmaceutical Suspensions影響因子(影響力)學(xué)科排名




書目名稱Pharmaceutical Suspensions網(wǎng)絡(luò)公開度




書目名稱Pharmaceutical Suspensions網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Pharmaceutical Suspensions被引頻次




書目名稱Pharmaceutical Suspensions被引頻次學(xué)科排名




書目名稱Pharmaceutical Suspensions年度引用




書目名稱Pharmaceutical Suspensions年度引用學(xué)科排名




書目名稱Pharmaceutical Suspensions讀者反饋




書目名稱Pharmaceutical Suspensions讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:38:42 | 只看該作者
第145552主題貼--第2樓 (沙發(fā))
板凳
發(fā)表于 2025-3-22 03:50:21 | 只看該作者
板凳
地板
發(fā)表于 2025-3-22 08:15:31 | 只看該作者
第4樓
5#
發(fā)表于 2025-3-22 10:16:36 | 只看該作者
5樓
6#
發(fā)表于 2025-3-22 14:50:46 | 只看該作者
6樓
7#
發(fā)表于 2025-3-22 20:49:05 | 只看該作者
7樓
8#
發(fā)表于 2025-3-22 23:37:44 | 只看該作者
8樓
9#
發(fā)表于 2025-3-23 02:18:34 | 只看該作者
9樓
10#
發(fā)表于 2025-3-23 08:11:26 | 只看該作者
10樓
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 16:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长寿区| 稷山县| 渝中区| 莱州市| 施秉县| 潍坊市| 平潭县| 深水埗区| 米林县| 吐鲁番市| 彭阳县| 平乐县| 文登市| 富阳市| 汪清县| 定边县| 安庆市| 扎鲁特旗| 太白县| 凤山县| 滨海县| 德钦县| 东平县| 鄯善县| 宿松县| 团风县| 安平县| 红安县| 镇安县| 泸西县| 弥勒县| 绥化市| 南川市| 和田市| 桦南县| 亳州市| 汶上县| 西昌市| 焉耆| 搜索| 绍兴县|